In insulin-naive T2D, weekly efsitora was noninferior to daily degludec for reducing HbA
1c
at 52 wk
Ann Intern Med
.
2025 Jan 7.
doi: 10.7326/ANNALS-24-03438-JC.
Online ahead of print.
Authors
Felipe Larios
1
,
Michael R Gionfriddo
1
,
Victor M Montori
1
;
ACP Journal Club Editorial Team at McMaster University
Affiliation
1
Mayo Clinic, Rochester, Minnesota, USA (F.L., M.R.G., V.M.M.).
PMID:
39761579
DOI:
10.7326/ANNALS-24-03438-JC
Abstract
GIM/FP/GP: [Formula: see text] Endocrinology: [Formula: see text].